Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc L-carnosine for Maintaining GERD Remission
NCT03467438Phase 4Unknown
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Nov 2018
- Primary completion
- Apr 2020
- Modality
- Peptides, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of polaprezinc in gastroesophageal reflux disease (GERD), sponsored by IRCCS San Matteo Foundation. Status: unknown.
02
Drugs
polaprezinc
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT03467438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03467438.